About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
MF HOLDINGS
MF
Holdings
Glaxosmithkline Pharmaceuticals Ltd.
BSE Code
500660
ISIN Demat
INE159A01016
Book Value
115.94
NSE Code
GLAXO
Dividend Yield %
1.64
Market Cap
556617.41
P/E
60.56
EPS
54.25
Face Value
10
Scheme Name
Market Val (In Crs.)
AUM(In Crs.)
Hold Percentage
SBI Midcap Fund-Reg(G)
488.59
20890.26
2.34
Kotak Large & Midcap Fund(G)
316.84
24912.67
1.27
Nippon India Pharma Fund(G)
291.47
8080.97
3.61
Aditya Birla SL ELSS Tax Saver Fund(IDCW)
271.13
14461.85
1.87
Nippon India Growth Mid Cap Fund(G)
161.01
33174.74
0.49
SBI Dividend Yield Fund-Reg(G)
129.62
8871.77
1.46
Kotak Flexicap Fund(G)
115.02
49130
0.23
Aditya Birla SL MNC Fund-Reg(G)
114.37
3371.41
3.39
Bandhan ELSS Tax Saver Fund-Reg(G)
97.73
6596.51
1.48
Baroda BNP Paribas Mid Cap Fund-Reg(G)
39.40
1981.66
1.99
Bandhan Multi Cap Fund-Reg(G)
38.78
2389.29
1.62
Kotak Manufacture in India Fund-Reg(G)
28.80
2266.05
1.27
Bajaj Finserv Large and Mid Cap Fund-Reg(G)
24.90
1763.85
1.41
Helios Flexi Cap Fund-Reg(G)
24.31
2779.34
0.87
Bajaj Finserv Multi Asset Allocation Fund-Reg(G)
19.40
1127.87
1.72
Baroda BNP Paribas Dividend Yield Fund-Reg(G)
17.28
958.25
1.80
Mahindra Manulife Flexi Cap Fund-Reg(G)
16.92
1401.56
1.21
Kotak ESG Exclusionary Strategy Fund-Reg(G)
15.84
847.62
1.87
ITI Mid Cap Fund-Reg(G)
12.48
1091.64
1.14
360 ONE Quant Fund-Reg(G)
10.90
631.71
1.73
Page
1
of
4
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.